Labshake search
Citations for TriLink BioTechnologies :
1 - 6 of 6 citations for Nucleic Acid Modification since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Genetics 2019Quote: ... Nucleic acid dosages were as follows: 1.5 μg Cas9 mRNA (Trilink Biotechnologies), 1 μg each chemically modified sgRNA (Synthego) ...
-
bioRxiv - Microbiology 2021Quote: ... CasRx mRNA with pseudouridine modification (pseudouridine-5’-triphosphate, TriLink) was synthesized using in vitro transcription (AmpliScribe T7-Flash Transcription Kit ...
-
bioRxiv - Immunology 2022Quote: ... Synthetic modified mRNA-LUC (with 5MoU modifications) was purchased from TriLink Technologies.
-
bioRxiv - Immunology 2022Quote: ... according to the manufacturer’s instructions with modifications as using the CleanCap® Reagent AG (TriLink, N-7413) and m1-pseudouridine-5’-triphosphate (TriLink ...
-
bioRxiv - Bioengineering 2024Quote: ... according to the manufacturer’s instructions with modifications as using the CleanCap® Reagent AG (TriLink, N-7413) and m1-pseudouridine-5’-triphosphate (TriLink ...
-
bioRxiv - Microbiology 2021Quote: ... pseudouridine-substituted Fc-conjugated RBD mRNA (amino acids 331– 524; GenBank: QHD43416.1) was purchased from TriLink Bio Technologies (San Diego ...